Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
A Phase II, Multi-center, Randomized, Double-blind Study Comparing the Safety and Efficacy of Two Doses of BC-3781 Versus Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated:  12/31/1969
BC-3781 Study Center 002
mi
from 43215
Chula Vista, CA
Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
A Phase II, Multi-center, Randomized, Double-blind Study Comparing the Safety and Efficacy of Two Doses of BC-3781 Versus Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated: 12/31/1969
BC-3781 Study Center 002
mi
from 43215
Chula Vista, CA
Click here to add this to my saved trials
Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
A Phase II, Multi-center, Randomized, Double-blind Study Comparing the Safety and Efficacy of Two Doses of BC-3781 Versus Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated:  12/31/1969
BC-3781 Study Center 001
mi
from 43215
La Mesa, CA
Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
A Phase II, Multi-center, Randomized, Double-blind Study Comparing the Safety and Efficacy of Two Doses of BC-3781 Versus Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated: 12/31/1969
BC-3781 Study Center 001
mi
from 43215
La Mesa, CA
Click here to add this to my saved trials
Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
A Phase II, Multi-center, Randomized, Double-blind Study Comparing the Safety and Efficacy of Two Doses of BC-3781 Versus Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated:  12/31/1969
BC-3781 Study Center 003
mi
from 43215
Oceanside, CA
Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
A Phase II, Multi-center, Randomized, Double-blind Study Comparing the Safety and Efficacy of Two Doses of BC-3781 Versus Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated: 12/31/1969
BC-3781 Study Center 003
mi
from 43215
Oceanside, CA
Click here to add this to my saved trials
Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
A Phase II, Multi-center, Randomized, Double-blind Study Comparing the Safety and Efficacy of Two Doses of BC-3781 Versus Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated:  12/31/1969
BC-3781 Study Center 012
mi
from 43215
Columbus, GA
Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
A Phase II, Multi-center, Randomized, Double-blind Study Comparing the Safety and Efficacy of Two Doses of BC-3781 Versus Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated: 12/31/1969
BC-3781 Study Center 012
mi
from 43215
Columbus, GA
Click here to add this to my saved trials
Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
A Phase II, Multi-center, Randomized, Double-blind Study Comparing the Safety and Efficacy of Two Doses of BC-3781 Versus Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated:  12/31/1969
BC-3781 Study Center 018
mi
from 43215
Savannah, GA
Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
A Phase II, Multi-center, Randomized, Double-blind Study Comparing the Safety and Efficacy of Two Doses of BC-3781 Versus Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated: 12/31/1969
BC-3781 Study Center 018
mi
from 43215
Savannah, GA
Click here to add this to my saved trials
Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
A Phase II, Multi-center, Randomized, Double-blind Study Comparing the Safety and Efficacy of Two Doses of BC-3781 Versus Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated:  12/31/1969
BC-3781 Study Center 021
mi
from 43215
Baton Rouge, LA
Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
A Phase II, Multi-center, Randomized, Double-blind Study Comparing the Safety and Efficacy of Two Doses of BC-3781 Versus Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated: 12/31/1969
BC-3781 Study Center 021
mi
from 43215
Baton Rouge, LA
Click here to add this to my saved trials
Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
A Phase II, Multi-center, Randomized, Double-blind Study Comparing the Safety and Efficacy of Two Doses of BC-3781 Versus Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated:  12/31/1969
BC-3781 Study Center 023
mi
from 43215
Lafayette, LA
Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
A Phase II, Multi-center, Randomized, Double-blind Study Comparing the Safety and Efficacy of Two Doses of BC-3781 Versus Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated: 12/31/1969
BC-3781 Study Center 023
mi
from 43215
Lafayette, LA
Click here to add this to my saved trials
Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
A Phase II, Multi-center, Randomized, Double-blind Study Comparing the Safety and Efficacy of Two Doses of BC-3781 Versus Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated:  12/31/1969
BC-3781 Study Center 004
mi
from 43215
Butte, MT
Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
A Phase II, Multi-center, Randomized, Double-blind Study Comparing the Safety and Efficacy of Two Doses of BC-3781 Versus Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated: 12/31/1969
BC-3781 Study Center 004
mi
from 43215
Butte, MT
Click here to add this to my saved trials
Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
A Phase II, Multi-center, Randomized, Double-blind Study Comparing the Safety and Efficacy of Two Doses of BC-3781 Versus Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated:  12/31/1969
BC-3781 Study Center 016
mi
from 43215
Somers Point, NJ
Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
A Phase II, Multi-center, Randomized, Double-blind Study Comparing the Safety and Efficacy of Two Doses of BC-3781 Versus Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated: 12/31/1969
BC-3781 Study Center 016
mi
from 43215
Somers Point, NJ
Click here to add this to my saved trials
Smoking Cessation in Nonunion, Malunion, Osseous Infection
Outcome of a Prospective Protocol for Smoking Cessation in Nonunion, Malunion, Osseous Infection, and Infected Nonunion Patients
Status: Enrolling
Updated:  12/31/1969
The Milton S. Hershey Medical Center
337
mi
from 43215
Hershey, PA
Smoking Cessation in Nonunion, Malunion, Osseous Infection
Outcome of a Prospective Protocol for Smoking Cessation in Nonunion, Malunion, Osseous Infection, and Infected Nonunion Patients
Status: Enrolling
Updated: 12/31/1969
The Milton S. Hershey Medical Center
337
mi
from 43215
Hershey, PA
Click here to add this to my saved trials
Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
Randomized Clinical Trial of Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection in Very-Low-Birth-Weight Infants
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
Randomized Clinical Trial of Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection in Very-Low-Birth-Weight Infants
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
Randomized Clinical Trial of Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection in Very-Low-Birth-Weight Infants
Status: Enrolling
Updated:  12/31/1969
George Washington University
328
mi
from 43215
Washington,
Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
Randomized Clinical Trial of Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection in Very-Low-Birth-Weight Infants
Status: Enrolling
Updated: 12/31/1969
George Washington University
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
Randomized Clinical Trial of Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection in Very-Low-Birth-Weight Infants
Status: Enrolling
Updated:  12/31/1969
University of Miami
992
mi
from 43215
Miami, FL
Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
Randomized Clinical Trial of Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection in Very-Low-Birth-Weight Infants
Status: Enrolling
Updated: 12/31/1969
University of Miami
992
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
Randomized Clinical Trial of Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection in Very-Low-Birth-Weight Infants
Status: Enrolling
Updated:  12/31/1969
Wayne State University
165
mi
from 43215
Detroit, MI
Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
Randomized Clinical Trial of Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection in Very-Low-Birth-Weight Infants
Status: Enrolling
Updated: 12/31/1969
Wayne State University
165
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
Randomized Clinical Trial of Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection in Very-Low-Birth-Weight Infants
Status: Enrolling
Updated:  12/31/1969
Case Western Reserve University, Rainbow Babies and Children's Hospital
129
mi
from 43215
Cleveland, OH
Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
Randomized Clinical Trial of Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection in Very-Low-Birth-Weight Infants
Status: Enrolling
Updated: 12/31/1969
Case Western Reserve University, Rainbow Babies and Children's Hospital
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
Randomized Clinical Trial of Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection in Very-Low-Birth-Weight Infants
Status: Enrolling
Updated:  12/31/1969
University of Tennessee
508
mi
from 43215
Memphis, TN
Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
Randomized Clinical Trial of Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection in Very-Low-Birth-Weight Infants
Status: Enrolling
Updated: 12/31/1969
University of Tennessee
508
mi
from 43215
Memphis, TN
Click here to add this to my saved trials
Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
Randomized Clinical Trial of Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection in Very-Low-Birth-Weight Infants
Status: Enrolling
Updated:  12/31/1969
UT Southwestern Medical Center
911
mi
from 43215
Dallas, TX
Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
Randomized Clinical Trial of Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection in Very-Low-Birth-Weight Infants
Status: Enrolling
Updated: 12/31/1969
UT Southwestern Medical Center
911
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
Randomized Clinical Trial of Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection in Very-Low-Birth-Weight Infants
Status: Enrolling
Updated:  12/31/1969
University of Vermont
590
mi
from 43215
Burlington, VT
Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
Randomized Clinical Trial of Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection in Very-Low-Birth-Weight Infants
Status: Enrolling
Updated: 12/31/1969
University of Vermont
590
mi
from 43215
Burlington, VT
Click here to add this to my saved trials
A Systematic Oral Care Program in Post-Mechanically Ventilated, Post-Intensive Care Patients
A Systematic Oral Care Program in Post-Mechanically Ventilated, Post-Intensive Care Patients
Status: Enrolling
Updated:  12/31/1969
Ohio State University
2
mi
from 43215
Columbus, OH
A Systematic Oral Care Program in Post-Mechanically Ventilated, Post-Intensive Care Patients
A Systematic Oral Care Program in Post-Mechanically Ventilated, Post-Intensive Care Patients
Status: Enrolling
Updated: 12/31/1969
Ohio State University
2
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Use of Recombinant Human Lactoferrin in Long-Term Care Patients With Feeding Tubes With Clostridium Difficile.
Use of Recombinant Human Lactoferrin in Long-Term Care Patients With Feeding Tubes to Manage Post-Antibiotic Colonization and Infection With Clostridium Difficile
Status: Enrolling
Updated:  9/14/2006
Johns Hopkins Bayview Medical Center
347
mi
from 43215
Baltimore, MD
Use of Recombinant Human Lactoferrin in Long-Term Care Patients With Feeding Tubes With Clostridium Difficile.
Use of Recombinant Human Lactoferrin in Long-Term Care Patients With Feeding Tubes to Manage Post-Antibiotic Colonization and Infection With Clostridium Difficile
Status: Enrolling
Updated: 9/14/2006
Johns Hopkins Bayview Medical Center
347
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Novel Home Care Device for High-Risk Diabetic Patients
Novel Home Care Device for High-Risk Diabetic Patients
Status: Enrolling
Updated:  7/11/2007
Kevin R. Higgins, DPM
1129
mi
from 43215
San Antonio, TX
Novel Home Care Device for High-Risk Diabetic Patients
Novel Home Care Device for High-Risk Diabetic Patients
Status: Enrolling
Updated: 7/11/2007
Kevin R. Higgins, DPM
1129
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections
Multicenter Evaluation of The Effectiveness of Source Control With Daily Chlorhexidine Skin Preparation in Reducing Nosocomial Infections Including MRSA and VRE
Status: Enrolling
Updated:  8/6/2007
Northwestern Memorial Hospital
274
mi
from 43215
Chicago, IL
Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections
Multicenter Evaluation of The Effectiveness of Source Control With Daily Chlorhexidine Skin Preparation in Reducing Nosocomial Infections Including MRSA and VRE
Status: Enrolling
Updated: 8/6/2007
Northwestern Memorial Hospital
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections
Multicenter Evaluation of The Effectiveness of Source Control With Daily Chlorhexidine Skin Preparation in Reducing Nosocomial Infections Including MRSA and VRE
Status: Enrolling
Updated:  8/6/2007
University of Iowa Hospitals and Clinics
460
mi
from 43215
Iowa City, IA
Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections
Multicenter Evaluation of The Effectiveness of Source Control With Daily Chlorhexidine Skin Preparation in Reducing Nosocomial Infections Including MRSA and VRE
Status: Enrolling
Updated: 8/6/2007
University of Iowa Hospitals and Clinics
460
mi
from 43215
Iowa City, IA
Click here to add this to my saved trials
Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections
Multicenter Evaluation of The Effectiveness of Source Control With Daily Chlorhexidine Skin Preparation in Reducing Nosocomial Infections Including MRSA and VRE
Status: Enrolling
Updated:  8/6/2007
Johns Hopkins Hospital
345
mi
from 43215
Baltimore, MD
Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections
Multicenter Evaluation of The Effectiveness of Source Control With Daily Chlorhexidine Skin Preparation in Reducing Nosocomial Infections Including MRSA and VRE
Status: Enrolling
Updated: 8/6/2007
Johns Hopkins Hospital
345
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections
Multicenter Evaluation of The Effectiveness of Source Control With Daily Chlorhexidine Skin Preparation in Reducing Nosocomial Infections Including MRSA and VRE
Status: Enrolling
Updated:  8/6/2007
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections
Multicenter Evaluation of The Effectiveness of Source Control With Daily Chlorhexidine Skin Preparation in Reducing Nosocomial Infections Including MRSA and VRE
Status: Enrolling
Updated: 8/6/2007
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections
Multicenter Evaluation of The Effectiveness of Source Control With Daily Chlorhexidine Skin Preparation in Reducing Nosocomial Infections Including MRSA and VRE
Status: Enrolling
Updated:  8/6/2007
Barnes Jewish Hospital
397
mi
from 43215
St. Louis, MO
Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections
Multicenter Evaluation of The Effectiveness of Source Control With Daily Chlorhexidine Skin Preparation in Reducing Nosocomial Infections Including MRSA and VRE
Status: Enrolling
Updated: 8/6/2007
Barnes Jewish Hospital
397
mi
from 43215
St. Louis, MO
Click here to add this to my saved trials
Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections
Multicenter Evaluation of The Effectiveness of Source Control With Daily Chlorhexidine Skin Preparation in Reducing Nosocomial Infections Including MRSA and VRE
Status: Enrolling
Updated:  8/6/2007
Memorial Sloan Kettering Cancer Center
480
mi
from 43215
New York, NY
Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections
Multicenter Evaluation of The Effectiveness of Source Control With Daily Chlorhexidine Skin Preparation in Reducing Nosocomial Infections Including MRSA and VRE
Status: Enrolling
Updated: 8/6/2007
Memorial Sloan Kettering Cancer Center
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections
Multicenter Evaluation of The Effectiveness of Source Control With Daily Chlorhexidine Skin Preparation in Reducing Nosocomial Infections Including MRSA and VRE
Status: Enrolling
Updated:  8/6/2007
Hunter Holmes McGuire Veteran Affairs Medical Center
342
mi
from 43215
Richmond, VA
Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections
Multicenter Evaluation of The Effectiveness of Source Control With Daily Chlorhexidine Skin Preparation in Reducing Nosocomial Infections Including MRSA and VRE
Status: Enrolling
Updated: 8/6/2007
Hunter Holmes McGuire Veteran Affairs Medical Center
342
mi
from 43215
Richmond, VA
Click here to add this to my saved trials
Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium Paratuberculosis
Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium Paratuberculosis
Status: Enrolling
Updated:  8/7/2007
MedStar Washington Hospital Center
328
mi
from 43215
Washington,
Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium Paratuberculosis
Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium Paratuberculosis
Status: Enrolling
Updated: 8/7/2007
MedStar Washington Hospital Center
328
mi
from 43215
Washington,
Click here to add this to my saved trials
30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of Volunteers
A 30-Day Double-Masked Study to Determine the Effect of Oral Valacyclovir or Oral Valacyclovir Plus Aspirin on the Shedding of Herpes Simplex Virus DNA in the Tears and Saliva of Volunteers Without Clinical Signs of Ocular Herpetic Disease
Status: Enrolling
Updated:  12/21/2007
LSU Eye Center
797
mi
from 43215
New Orleans, LA
30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of Volunteers
A 30-Day Double-Masked Study to Determine the Effect of Oral Valacyclovir or Oral Valacyclovir Plus Aspirin on the Shedding of Herpes Simplex Virus DNA in the Tears and Saliva of Volunteers Without Clinical Signs of Ocular Herpetic Disease
Status: Enrolling
Updated: 12/21/2007
LSU Eye Center
797
mi
from 43215
New Orleans, LA
Click here to add this to my saved trials
30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of Volunteers
A 30-Day Double-Masked Study to Determine the Effect of Oral Valacyclovir or Oral Valacyclovir Plus Aspirin on the Shedding of Herpes Simplex Virus DNA in the Tears and Saliva of Volunteers Without Clinical Signs of Ocular Herpetic Disease
Status: Enrolling
Updated:  12/21/2007
Children's Hospital
799
mi
from 43215
New Orleans, LA
30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of Volunteers
A 30-Day Double-Masked Study to Determine the Effect of Oral Valacyclovir or Oral Valacyclovir Plus Aspirin on the Shedding of Herpes Simplex Virus DNA in the Tears and Saliva of Volunteers Without Clinical Signs of Ocular Herpetic Disease
Status: Enrolling
Updated: 12/21/2007
Children's Hospital
799
mi
from 43215
New Orleans, LA
Click here to add this to my saved trials
Effect of Denileukin Diftitox on Immune System in CTCL Patients
Effect of Denileukin Diftitox in T-Regulatory Cells in CTCL Patients
Status: Enrolling
Updated:  12/26/2007
University of Pittsubrgh Medical Center
165
mi
from 43215
Pittsburgh, PA
Effect of Denileukin Diftitox on Immune System in CTCL Patients
Effect of Denileukin Diftitox in T-Regulatory Cells in CTCL Patients
Status: Enrolling
Updated: 12/26/2007
University of Pittsubrgh Medical Center
165
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Study of Chlorhexidine as the Hub Antiseptic to Prevent Catheter Related Infections in Newborn Infants
Chlorhexidine and the Prevention of Central Catheter Related Infections in Neonates
Status: Enrolling
Updated:  5/28/2008
University of Rochester
354
mi
from 43215
Rochester, NY
Study of Chlorhexidine as the Hub Antiseptic to Prevent Catheter Related Infections in Newborn Infants
Chlorhexidine and the Prevention of Central Catheter Related Infections in Neonates
Status: Enrolling
Updated: 5/28/2008
University of Rochester
354
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
Evaluation of Fever Occurring in Labor in Patients Receiving Epidural Anesthesia
Evaluation of Intrapartum Fever in Patients Receiving Epidural Anesthesia
Status: Enrolling
Updated:  6/5/2008
Long Beach Memorial Medical Center
1976
mi
from 43215
Long Beach, CA
Evaluation of Fever Occurring in Labor in Patients Receiving Epidural Anesthesia
Evaluation of Intrapartum Fever in Patients Receiving Epidural Anesthesia
Status: Enrolling
Updated: 6/5/2008
Long Beach Memorial Medical Center
1976
mi
from 43215
Long Beach, CA
Click here to add this to my saved trials
Evaluation of Fever Occurring in Labor in Patients Receiving Epidural Anesthesia
Evaluation of Intrapartum Fever in Patients Receiving Epidural Anesthesia
Status: Enrolling
Updated:  6/5/2008
UCI Medical Center
1958
mi
from 43215
Orange, CA
Evaluation of Fever Occurring in Labor in Patients Receiving Epidural Anesthesia
Evaluation of Intrapartum Fever in Patients Receiving Epidural Anesthesia
Status: Enrolling
Updated: 6/5/2008
UCI Medical Center
1958
mi
from 43215
Orange, CA
Click here to add this to my saved trials
Accuracy and Acceptability of Self-Diagnostic Methods for Vaginitis in Adolescent Females
Taking Charge of my Health: A Trial to Investigate the Accuracy and Acceptability of Self-Diagnostic Methods for Vaginitis in Adolescent Females
Status: Enrolling
Updated:  6/25/2008
Cincinnati Children's Hospital Medical Center
97
mi
from 43215
Cincinnati, OH
Accuracy and Acceptability of Self-Diagnostic Methods for Vaginitis in Adolescent Females
Taking Charge of my Health: A Trial to Investigate the Accuracy and Acceptability of Self-Diagnostic Methods for Vaginitis in Adolescent Females
Status: Enrolling
Updated: 6/25/2008
Cincinnati Children's Hospital Medical Center
97
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
The Efficacy of Crotaline Fab Antivenom for Copperhead Snake Envenomations
The Efficacy of Crotaline Fab Antivenom for Copperhead Snake Envenomations
Status: Enrolling
Updated:  7/16/2008
Carolinas Medical Center
349
mi
from 43215
Charlotte, NC
The Efficacy of Crotaline Fab Antivenom for Copperhead Snake Envenomations
The Efficacy of Crotaline Fab Antivenom for Copperhead Snake Envenomations
Status: Enrolling
Updated: 7/16/2008
Carolinas Medical Center
349
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
The Efficacy of Crotaline Fab Antivenom for Copperhead Snake Envenomations
The Efficacy of Crotaline Fab Antivenom for Copperhead Snake Envenomations
Status: Enrolling
Updated:  7/16/2008
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
The Efficacy of Crotaline Fab Antivenom for Copperhead Snake Envenomations
The Efficacy of Crotaline Fab Antivenom for Copperhead Snake Envenomations
Status: Enrolling
Updated: 7/16/2008
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
The Efficacy of Crotaline Fab Antivenom for Copperhead Snake Envenomations
The Efficacy of Crotaline Fab Antivenom for Copperhead Snake Envenomations
Status: Enrolling
Updated:  7/16/2008
Richland Memorial Hospital
424
mi
from 43215
Columbia, SC
The Efficacy of Crotaline Fab Antivenom for Copperhead Snake Envenomations
The Efficacy of Crotaline Fab Antivenom for Copperhead Snake Envenomations
Status: Enrolling
Updated: 7/16/2008
Richland Memorial Hospital
424
mi
from 43215
Columbia, SC
Click here to add this to my saved trials
The Efficacy of Crotaline Fab Antivenom for Copperhead Snake Envenomations
The Efficacy of Crotaline Fab Antivenom for Copperhead Snake Envenomations
Status: Enrolling
Updated:  7/16/2008
Medical College of Virigina/Virginia Commonwealth University Hospital
344
mi
from 43215
Richmond, VA
The Efficacy of Crotaline Fab Antivenom for Copperhead Snake Envenomations
The Efficacy of Crotaline Fab Antivenom for Copperhead Snake Envenomations
Status: Enrolling
Updated: 7/16/2008
Medical College of Virigina/Virginia Commonwealth University Hospital
344
mi
from 43215
Richmond, VA
Click here to add this to my saved trials
Continuous Exhaled Breath Condensate pH in Mechanically Ventilated Patients
Phase 2 Continuous Exhaled Breath Condensate pH in Mechanically Ventilated Patients
Status: Enrolling
Updated:  8/6/2008
University of Virginia
275
mi
from 43215
Charlottesville, VA
Continuous Exhaled Breath Condensate pH in Mechanically Ventilated Patients
Phase 2 Continuous Exhaled Breath Condensate pH in Mechanically Ventilated Patients
Status: Enrolling
Updated: 8/6/2008
University of Virginia
275
mi
from 43215
Charlottesville, VA
Click here to add this to my saved trials
Acetaminophen for Fetal Tachycardia: a Randomized Pilot Trial
Acetaminophen for Fetal Tachycardia: a Randomized Pilot Trial
Status: Enrolling
Updated:  9/8/2008
New York Hospital Medical Center of Queens
487
mi
from 43215
Flushing, NY
Acetaminophen for Fetal Tachycardia: a Randomized Pilot Trial
Acetaminophen for Fetal Tachycardia: a Randomized Pilot Trial
Status: Enrolling
Updated: 9/8/2008
New York Hospital Medical Center of Queens
487
mi
from 43215
Flushing, NY
Click here to add this to my saved trials
Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection
The Safety and Efficacy of Intravenous Anti-D for the Treatment of Thrombocytopenia in Patients With HCV Infection Prior to or During Treatment With Pegylated-Interferon and Ribavirin
Status: Enrolling
Updated:  9/25/2008
New York Presbyterian Hospital (Cornell)
480
mi
from 43215
New York, NY
Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection
The Safety and Efficacy of Intravenous Anti-D for the Treatment of Thrombocytopenia in Patients With HCV Infection Prior to or During Treatment With Pegylated-Interferon and Ribavirin
Status: Enrolling
Updated: 9/25/2008
New York Presbyterian Hospital (Cornell)
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Conversion of CellCept to Myfortic: A Prospective Study in Liver Transplant Recipients
Conversion of CellCept to Myfortic: A Prospective Study on the Tolerability and Safety of Myfortic in Liver Transplant Recipients
Status: Enrolling
Updated:  10/2/2008
University of Pittsburgh Medical Center
165
mi
from 43215
Pittsburgh, PA
Conversion of CellCept to Myfortic: A Prospective Study in Liver Transplant Recipients
Conversion of CellCept to Myfortic: A Prospective Study on the Tolerability and Safety of Myfortic in Liver Transplant Recipients
Status: Enrolling
Updated: 10/2/2008
University of Pittsburgh Medical Center
165
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Myometrial Biopsy for the Detection of Infection
Myometrial Biopsy for the Detection of Infection
Status: Enrolling
Updated:  10/28/2008
Woman's Hospital of Texas
996
mi
from 43215
Houston, TX
Myometrial Biopsy for the Detection of Infection
Myometrial Biopsy for the Detection of Infection
Status: Enrolling
Updated: 10/28/2008
Woman's Hospital of Texas
996
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Zinc for the Treatment of Herpes Simplex Labialis (HSL)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of Zinc for the Treatment of Herpes Simplex Labialis (HSL)
Status: Enrolling
Updated:  12/16/2008
Steven Messer ND, DHANP
1656
mi
from 43215
Tempe, AZ
Zinc for the Treatment of Herpes Simplex Labialis (HSL)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of Zinc for the Treatment of Herpes Simplex Labialis (HSL)
Status: Enrolling
Updated: 12/16/2008
Steven Messer ND, DHANP
1656
mi
from 43215
Tempe, AZ
Click here to add this to my saved trials
Zinc for the Treatment of Herpes Simplex Labialis (HSL)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of Zinc for the Treatment of Herpes Simplex Labialis (HSL)
Status: Enrolling
Updated:  12/16/2008
Deborah Thompson, MD MSPH
1282
mi
from 43215
Santa Fe, NM
Zinc for the Treatment of Herpes Simplex Labialis (HSL)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of Zinc for the Treatment of Herpes Simplex Labialis (HSL)
Status: Enrolling
Updated: 12/16/2008
Deborah Thompson, MD MSPH
1282
mi
from 43215
Santa Fe, NM
Click here to add this to my saved trials
Zinc for the Treatment of Herpes Simplex Labialis (HSL)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of Zinc for the Treatment of Herpes Simplex Labialis (HSL)
Status: Enrolling
Updated:  12/16/2008
Benjamin Kligler, MD
479
mi
from 43215
New York, NY
Zinc for the Treatment of Herpes Simplex Labialis (HSL)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of Zinc for the Treatment of Herpes Simplex Labialis (HSL)
Status: Enrolling
Updated: 12/16/2008
Benjamin Kligler, MD
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting
Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting
Status: Enrolling
Updated:  1/23/2009
DWHA
354
mi
from 43215
Durham, NC
Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting
Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting
Status: Enrolling
Updated: 1/23/2009
DWHA
354
mi
from 43215
Durham, NC
Click here to add this to my saved trials
A Phase 2b Trial of EPB-348 for the Treatment of Herpes Zoster
A Randomized, Double-Blind, Active-Controlled, Multi-Center, Parallel-Group Dose-Ranging Study Assessing the Safety and Efficacy of EPB-348 Versus Valacyclovir Among Immunocompetent Patients With an Acute Episode of Herpes Zoster
Status: Enrolling
Updated:  1/26/2009
Center for Clinical Studies-Medical Center
995
mi
from 43215
Houston, TX
A Phase 2b Trial of EPB-348 for the Treatment of Herpes Zoster
A Randomized, Double-Blind, Active-Controlled, Multi-Center, Parallel-Group Dose-Ranging Study Assessing the Safety and Efficacy of EPB-348 Versus Valacyclovir Among Immunocompetent Patients With an Acute Episode of Herpes Zoster
Status: Enrolling
Updated: 1/26/2009
Center for Clinical Studies-Medical Center
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials